FHI vs MSCI
Federated Hermes vs MSCI Inc. — AI-powered side-by-side comparison
FHI
Federated Hermes
70
Buy
VS
| Metric | FHI | MSCI |
|---|
| AI Score |
70
|
56
|
| Price |
$65.17
|
$566.11
|
| P/E Ratio |
11.90×
|
31.43×
|
| ROE |
33.7%
|
-45.3%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
71.6%
|
83.0%
|
| Debt / Equity |
0.36×
|
-2.43×
|
| Dividend Yield |
2.2%
|
1.4%
|
| RSI (14) |
68.7
|
53.6
|
| Beta |
0.627
|
1.222
|
| Expected Upside |
—
|
+1.0%
|
AI Committee View
Current Innellis committee reasoning for FHI versus MSCI.
FHI leads by 14 points.
FHI scores 70/100 (Buy) versus MSCI at 56/100 (Buy).
FHI Committee View
100% agreement
6 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is sector concentration is already high (hhi 3063.01). The committee is constructive but not yet at full conviction.
Bull Case
- P/E of 11.5 is inexpensive for the broad market — Value
- ROE of 34.0% shows genuine earnings power backing the valuation — Value
- Dividend yield of 3.5% pays you to wait — Value
Bear Case
- MACD histogram negative -- bearish momentum — Technical
MSCI Committee View
50% agreement
6 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — quarter-over-quarter growth rate is accelerating, not just positive. Risk Analyst remains cautious — high leverage (debt-to-equity 5.18) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- ROE of 108.7% shows genuine earnings power backing the valuation — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- P/E of 29.9 is moderate-to-rich — Value
- Price-to-book of 28.7x prices in significant intangible value — Value
- Debt-to-equity of 5.18 adds balance-sheet risk to the value case — Value